A Clinical Study to Assess the Role of Bhunimba Powder in Healing Chronic Non-Healing Ulcers

An Open Label Double Arm Controlled Clinical Trial To Evaluate The Efficacy Of Bhunimba Avachoornana In Dushta Vrana,Chronic Non Healing Ulcer - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103876

Enrollment

Registered

2026-02-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS-

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient diagnosed with Dushtavrana having the features of Vrana presenting with Durgandha, Puya Shrava, Vedana and Daha. 2.Age between 20 to 60 years irrespective of gender, religion, place and socio-economic status. 3.Ulcer size within 5-cm length x breadth and 1-2cm depth 4.Chronicity up to one year.

Exclusion criteria

Exclusion criteria: Patient aged about 60 years. Patient with Tuberculosis,Malignancy,Severe bleeding disorders,Multiple Ulcers ,Gangrene wound in specific areas like joints,bones and Diabetic mellitus HbA1C greater than 8

Design outcomes

Primary

Measure	Time frame
1.Changes in the status of Dushtavrana. 2.Reduction in Circumference of the wound Length, Width and Depth. 3.Reduction in Exudate quantity, Odour, Pain and Slough 4.Formation of Granulation Tissue. 5.four weeksTimepoint: 1.Changes in the status of Dushtavrana. 2.Reduction in Circumference of the wound Length, Width and Depth 3.Reduction in Exudate quantity, Odour, Pain and Slough 4.Formation of Granulation Tissue. 5.four weeks.	—

Measure

Time frame

1.Changes in the status of Dushtavrana. 2.Reduction in Circumference of the wound Length, Width and Depth. 3.Reduction in Exudate quantity, Odour, Pain and Slough 4.Formation of Granulation Tissue. 5.four weeksTimepoint: 1.Changes in the status of Dushtavrana. 2.Reduction in Circumference of the wound Length, Width and Depth 3.Reduction in Exudate quantity, Odour, Pain and Slough 4.Formation of Granulation Tissue. 5.four weeks.

—

Secondary

Measure	Time frame
Improvement in the quality of life.Timepoint: 14 days	—

Countries

India

Contacts

Public ContactDr Prathibha H C

SDM Institute of Ayurveda and Hospital

drshankar@sdmayurbangalore.in9535581371

Outcome results